Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML

NCT03709576 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Funding pulled

Conditions

Acute Myeloid Leukemia (AML)

Interventions

DRUG: Pevonedistat
PROCEDURE: transplant
DRUG: Azacitidine

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]
[object Object]